Table 2.

Unmatched clinical outcomes and efficacy parameters after 3 y, as documented in patients' EMR

	Diuretics	Beta blockers	RAS blockers	CCB
N	13 808	20 538	35 783	9159
Three‐y outcomes (30 until 1095 d after index); before propensity matching
First stroke (I63) (%)	0.7	1.3	0.8	1.3
Any cerebrovascular outcome (I60‐I69) (%)	2.5	3.9	2.4	4.1
Myocardial infarction (I21) (%)	0.2	0.9	0.2	0.3
Any ischemic heart disease (I20‐I25) (%)	2.8	6.6	2.6	4.1
Chronic kidney disease (N18, I12, I13) (%)	2.3	2.4	2.6	3.0
Any of these CV outcomes (%)	5.2	9.5	5.4	7.6
Efficacy parameters
LDL cholesterol, mg/dL	114.7	108.1	109.24	110.32
	−2.9	−4.4	−6.1	−3.3
Uncontrolled BP values, any episode (%)	42.9	45.9	28.7	35.8
Man systolic BP, most recent value, mm Hg	128.7	128.1	128.9	132.2
±SD	15.4	16.7	15.1	16.2
Difference to baseline	−4.9	−3.6	−5.8	−4.8
Mean diastolic BP, most recent value, mm Hg	77.1	76.0	77.2	77.7
±SD	10.5	10.6	10.0	10.5
Difference to baseline	−3.1	−2.2	−3.8	−3.2
Heart rate/min	78.1	72.7	77.3	77.1
Difference to baseline	−2.2	−4.9	−1.5	−2.1
Mean C‐reactive protein, most recent value, mg/L, mean	8.3	8.5	9.3	6.8
Difference to baseline	−1.2	0.8	0.4	−0.1